NCT02007837 - Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial | Biotech Hunter

Enrollment

440

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

April 30, 2018

Study Completion Date

August 31, 2018

Conditions

Pregnancy Induced Hypertension

Interventions

DRUG

Combined aspirin and multinutrient supplement

Single capsule with 80mg low-dose aspirin, 1.2 grams calcium, 600 IU vitamin D, 5mg folic acid and 1000 ug vitamin B12 mixed.

OTHER

Daily text reminder text messages

Trial Locations (2)

La General Hospital, Accra

Ridge Regional Hospital, Accra